BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 9362355)

  • 1. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of the aminopyrine breath test and the Child-Pugh score to urinary sodium retention in patients with liver cirrhosis.
    Wensing G; Lotterer E; Ahlsdorf H; Kügler CF; Hahn EG; Fleig WE
    Z Gastroenterol; 1995 Mar; 33(3):150-4. PubMed ID: 7754646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
    Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
    Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between oxidative hepatic metabolism, urinary sodium excretion and sympathetic nerve activity in experimental cirrhosis in the rat.
    Wensing G; Sabra R; Branch RA
    Z Gastroenterol; 1995 Jan; 33(1):1-4. PubMed ID: 7886979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of liver function by the aminopyrine breath test.
    Villeneuve JP; Arsène D; Huet PM
    Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
    Lao XM; Zhang YQ; Guan YX; Guo RP; Lin XJ; Yuan YF; Li JQ; Li GH
    Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis.
    Pirlich M; Selberg O; Böker K; Schwarze M; Müller MJ
    Hepatology; 1996 Dec; 24(6):1422-7. PubMed ID: 8938174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
    Gerbes AL; Gülberg V; Waggershauser T; Holl J; Reiser M
    Hepatology; 1998 Sep; 28(3):683-8. PubMed ID: 9731559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of quantitative liver function tests to clinical, laboratory chemical and biopsy findings in patients with liver diseases].
    Albers I; Hartmann H; Creutzfeldt W
    Z Gastroenterol; 1988 Feb; 26(2):130-6. PubMed ID: 2577930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagal dysfunction and impaired urinary sodium and water excretion in cirrhosis.
    Hendrickse MT; Triger DR
    Am J Gastroenterol; 1994 May; 89(5):750-7. PubMed ID: 8172151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinomas do not compromise quantitative tests of liver function.
    Ganslmayer M; Ocker M; Zopf S; Schuppan D; Hahn EG; Herold C
    Hepatogastroenterology; 2005; 52(63):881-4. PubMed ID: 15966225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium retention and hepatic function after two-thirds hepatectomy in the rat.
    Ohno T; Sabra R; Branch RA
    Hepatology; 1991 Sep; 14(3):511-7. PubMed ID: 1874496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].
    Navasa M; García-Pagán JC; Bosch J; Rodés J
    Med Clin (Barc); 1992 Feb; 98(8):290-4. PubMed ID: 1560714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.